Position in BIIB
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$354,554
+$15,394 QoQ
Shares Held
1,641
-11.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#640
of 1,031 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Investors Research Corp holds $5,482,615 across 10 Drug Manufacturers - General names. BIIB ranks #7 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
8,779 | $1,128,101 | |
| 2 | PFE |
Pfizer Inc
|
38,962 | $938,204 | |
| 3 | NVO |
Novo Nordisk A S
|
18,225 | $873,706 | |
| 4 | GSK |
GSK plc
|
14,952 | $783,783 | |
| 5 | SNY |
Sanofi
|
16,468 | $702,524 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,628 | $497,145 | |
| 7 | BIIB |
Biogen Inc.
This page
|
1,641 | $354,554 | |
| 8 | AZN |
Astrazeneca PLC
|
642 | $121,736 |
All Filings in BIIB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $354,554 | 1,641 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $339,160 | 1,850 | Shares | Sole | 2026-04-03 | |
| 2025-12-31 | $325,581 | 1,850 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $259,148 | 1,850 | Shares | Sole | 2025-10-02 | |
| 2025-06-30 | $232,341 | 1,850 | Shares | Sole | 2025-07-07 | |
| 2020-09-30 | $2,836 | 10 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $2,675 | 10 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $3,163 | 10 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||